Age, median years (range)
|
63 (28–86)
|
59.5 (32–83)
|
67 (28–86)
|
<0.01
|
Sex, n (%)
| | | |
0.5
|
Male
|
115 (79)
|
62 (82)
|
53 (77)
| |
Female
|
30 (21)
|
14 (18)
|
16 (23)
| |
ECOG PS, n (%)
| | | |
<0.001
|
0
|
102 (70)
|
64 (84)
|
38 (55)
| |
1
|
32 (22)
|
10 (13)
|
22 (32)
| |
2
|
10 (7)
|
2 (3)
|
8 (12)
| |
Missing
|
1 (1)
|
-
|
1 (1)
| |
Smoking status, n (%)
| | | |
0.2
|
Non-smoker
|
44 (30)
|
24 (32)
|
20 (29)
| |
Ex-smoker
|
61 (42)
|
36 (47)
|
25 (36)
| |
Current smoker
|
37 (26)
|
15 (20)
|
22 (32)
| |
Missing
|
3 (2)
|
1 (1)
|
2 (3)
| |
Tumour site, n (%)
| | | |
<0.001
|
Lip and oral cavity
|
25 (17)
|
0 (0)
|
25 (36)
| |
Nasopharynx
|
8 (6)
|
0 (0)
|
8 (12)
| |
Oropharynx
|
76 (52)
|
76 (100)
|
0 (0)
| |
Hypopharynx
|
12 (8)
|
0 (0)
|
12 (17)
| |
Larynx
|
24 (17)
|
0 (0)
|
24 (35)
| |
Tumour stage, n (%)
| | | |
0.05
|
T1
|
35 (24)
|
24 (32)
|
11 (16)
| |
T2
|
52 (36)
|
29 (38)
|
23 (33)
| |
T3
|
36 (25)
|
15 (19)
|
21 (30)
| |
T4
|
22 (15)
|
8 (11)
|
14 (20)
| |
Nodal stage, n (%)
| | | |
<0.001
|
N0
|
44 (30)
|
11 (14)
|
33 (48)
| |
N1
|
36 (25)
|
22 (29)
|
14 (20)
| |
N2
|
60 (41)
|
41 (54)
|
19 (28)
| |
N3
|
5 (3)
|
2 (3)
|
3 (4)
| |
AJCC stage, n (%)
| | | |
0.2
|
I
|
9 (6)
|
4 (5)
|
5 (7)
| |
II
|
35 (24)
|
18 (24)
|
17 (25)
| |
III
|
74 (51)
|
44 (58)
|
30 (43)
| |
IV
|
27 (19)
|
10 (13)
|
17 (27)
| |
p16 tumour status, n (%)
| | | |
<0.001
|
Negative
|
48 (51)
|
7 (16)
|
41 (80)
| |
Positive
|
47 (49)
|
37 (84)
|
10 (20)
| |
Missing
|
50
|
32
|
19
| |
Treatment, n (%)
| | | |
<0.001
|
Radiotherapy
|
17 (12)
|
10 (13)
|
7 (10)
| |
Postoperative radiotherapy
|
29 (20)
|
3 (4)
|
26 (38)
| |
Chemoradiotherapy
|
88 (61)
|
61 (80)
|
27 (39)
| |
Postoperative chemoradiotherapy
|
11 (8)
|
2 (3)
|
9 (13)
| |
Neutrophils, median counts (range) x 109 cells/L
|
5.10 (1.10 - 11.90)
|
4.60 (1.10 - 11.90)
|
5.30 (2.10 - 11.80)
|
0.2
|
Lymphocytes, median counts (range) x 109 cells/L
|
1.60 (0.20 - 10.70)
|
1.60 (0.40 - 3.40)
|
1.70 (0.20 - 10.70)
|
0.1
|
NLR, median counts (range) x 109 cells/L
|
3.11 (0.41 - 29.75)
|
3.11 (1.30 - 29.75)
|
3.11 (0.41 - 16.00)
|
0.9
|
NLR, n (%)
| | | |
0.7
|
Low (≤5)
|
116 (80)
|
60 (79)
|
56 (81)
| |
High (>5)
|
29 (20)
|
16 (21)
|
13 (19)
| |